For: | Wang SW, Chang YW, Wang C, Cheng YM, Hsieh TH, Wang CC, Kao JH. Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World J Hepatol 2024; 16(12): 1429-1440 [PMID: 39744191 DOI: 10.4254/wjh.v16.i12.1429] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v16/i12/1429.htm |
Number | Citing Articles |
1 |
Ammara A Majeed, Amna S Butt. Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction. World Journal of Hepatology 2025; 17(1): 100968 doi: 10.4254/wjh.v17.i1.100968
|
2 |
Yu-Ming Cheng, Shao-Wen Wang, Ching Wang, Chia-Chi Wang. Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease. Tzu Chi Medical Journal 2025; 37(2): 152 doi: 10.4103/tcmj.tcmj_232_24
|
3 |
Jing-ya Yang, Li Tao, Dengji Lou, Nimesha M. Patabendige, Aseni N. Ediriweera, Shujuan Liu, Wenhua Lu, Entaj Tarafder, Sylvie Rapior, Kalani K. Hapuarachchi. Innovative applications of medicinal mushrooms in functional foods and nutraceuticals: a focus on health-boosting beverages. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1605301
|